Company: ERAS
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042682
Chunk: 145

Company: Erasca, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 16
Chunk 145
---
 
    10-K
     
    3/27/2024
     
    97

    101.INS
     
    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

    X

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

    X

    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    X

#        Indicates management contract or compensatory plan.

†       Portions of this exhibit have been omitted for confidentiality purposes. 

*       This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

144

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

    Erasca, Inc.

    Date: March 20, 2025
     
    By:
    /s/ Jonathan E. Lim 

    Jonathan E. Lim, M.D.

    Chairman, Chief Executive Officer and Co-Founder

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/ Jonathan E. Lim 
     
    Chairman, Chief Executive Officer and Co-Founder
     
    March 20, 2025

    Jonathan E. Lim, M.D.
     
     (Principal Executive Officer)

    /s/ David M. Chacko
     
    Chief Financial Officer and Chief Business Officer
     
    March 20, 2025

    David M. Chacko, M.D.
     
      (Principal Financial and Accounting Officer)

    /s/ James A. Bristol
     
    Director 
     
     March 20, 2025

    James A. Bristol, Ph.D.

    /s/ Alexander W. Casdin
     
    Director  
     
     March 20, 2025

    Alexander W. Casdin

    /s/ Julie Hambleton
     
    Director